The new building space was completed last year and sees Vetter’s development laboratories housed in one 1,800-square-meter facility in Ravensburg.
The facilities include non-good manufacturing practice (GMP) laboratory space and equipment, as well as a GMP analytical laboratory. In addition, the combined space will offer process development capabilities, as well as specification testing of packaging system, chemical-analytical and biochemical analysis and particle characterization.
In total, 50 employees will staff the building and the contract development and manufacturing organization (CDMO) noted that being housed under one roof will allow colleagues to “share expertise and know-how to improve and simplify information exchange.”
As well as improving cooperation, the merged lab space is expected to reduce handling issues and allow for the synchronization of processes, as previously development took place in different locations in Ravensburg and Langenargen.
Customers will benefit by being able to follow the development cycle of their project, suggested Claus Feussner, SVP of Development Service.
“Now [clients] can follow a complete development process and its individual steps, since it proceeds throughout the labs, all within the same building,” he said.
Though the new building is complete, the company will continue to expand within the space over the course of 2020 and will add further analytical equipment.
The investment in its European capabilities follows similar investment in its US operations, which saw it expand its clinical manufacturing facility in Chicago last year. The company also launched a pilot project looking at automating its packaging services.